Saturna Capital CORP lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 216,140 shares of the medical instruments supplier’s stock after acquiring an additional 1,140 shares during the quarter. Saturna Capital CORP owned 0.09% of DENTSPLY SIRONA worth $12,927,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in XRAY. Rothschild Asset Management Inc. grew its position in DENTSPLY SIRONA by 6.2% during the second quarter. Rothschild Asset Management Inc. now owns 7,606 shares of the medical instruments supplier’s stock valued at $493,000 after buying an additional 441 shares during the period. Korea Investment CORP lifted its holdings in DENTSPLY SIRONA by 139.9% during the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after purchasing an additional 1,251 shares in the last quarter. Beach Investment Management LLC. purchased a new position in DENTSPLY SIRONA during the second quarter valued at approximately $3,057,000. Advisor Partners LLC lifted its holdings in DENTSPLY SIRONA by 7.5% during the second quarter. Advisor Partners LLC now owns 4,867 shares of the medical instruments supplier’s stock valued at $316,000 after purchasing an additional 340 shares in the last quarter. Finally, Pioneer Investment Management Inc. lifted its holdings in DENTSPLY SIRONA by 47.1% during the second quarter. Pioneer Investment Management Inc. now owns 1,301,449 shares of the medical instruments supplier’s stock valued at $84,386,000 after purchasing an additional 416,769 shares in the last quarter. Institutional investors own 96.58% of the company’s stock.

In other DENTSPLY SIRONA news, insider Mark Thierer purchased 77,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, November 13th. The shares were bought at an average price of $66.04 per share, for a total transaction of $5,085,080.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Nicholas W. Alexos purchased 50,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, November 13th. The stock was acquired at an average price of $65.85 per share, for a total transaction of $3,292,500.00. The disclosure for this purchase can be found here. 1.99% of the stock is currently owned by insiders.

Several brokerages have weighed in on XRAY. HC Wainwright downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price target on the stock. in a report on Thursday, November 30th. Stephens began coverage on shares of DENTSPLY SIRONA in a report on Tuesday, November 28th. They set an “overweight” rating and a $75.00 price target on the stock. BidaskClub downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a report on Saturday. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price target on the stock in a report on Monday, November 6th. Finally, TheStreet raised shares of DENTSPLY SIRONA from a “c” rating to a “b-” rating in a report on Friday, November 3rd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $67.73.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at $65.61 on Wednesday. DENTSPLY SIRONA Inc. has a 1-year low of $52.53 and a 1-year high of $68.98. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59. The company has a market cap of $15,177.45, a price-to-earnings ratio of 26.33, a PEG ratio of 2.62 and a beta of 1.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, topping the consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. During the same quarter in the previous year, the firm earned $0.66 earnings per share. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. research analysts expect that DENTSPLY SIRONA Inc. will post 2.66 EPS for the current fiscal year.

WARNING: This story was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/12/06/dentsply-sirona-inc-xray-shares-bought-by-saturna-capital-corp.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.